CEO Jamal Rushdy and new CFO Hilary Spence present a business overview and an update of the ChondroMimetic® clinical study.
Contents
Jamal Rushdy CEO introduction – 00:00
Regenerative medicine overview – 00:53
What Collagen Solutions does – 2:24
Core business model – 5:36
Revenue trend – 9:23
ChondroMimetic® introduction – 9:50
Knee cartilage disease progression – 12:12
Current treatments – 14:40
ChondroMimetic® clinical study – 17:19
Study highlights – 18:15
Study data introduction – 22:00
Study results – 23:35
Market opportunities – 27:46
Key competitive differentiators – 31:39
Conclusions & next steps – 33:14
Q&A – 35:09